Siemens AG (SIEGn.DE) is reconsidering its majority stake in Siemens Healthineers (SHLG.DE), its medical technology subsidiary, according to CFO Ralf Thomas in an interview with Handelsblatt. The company’s 75% stake, valued at €45 billion ($46.91 billion), may no longer align with Siemens’ broader strategic goals, as Thomas noted that the synergies between the two companies are not substantial enough to justify such a capital commitment.
Thomas emphasized that Siemens is reassessing its opportunities in the healthcare sector and will determine Healthineers’ future role based on economic considerations. A conclusion will be presented at Siemens’ capital markets day in late 2025.
While Siemens had previously maintained its majority stake in Healthineers following its 2018 spin-off, the company is now contemplating selling up to 5% of its shares to fund the acquisition of U.S. software company Altair (ALTR.O).
Regarding the Mobility division, which investors have suggested spinning off, Thomas expressed confidence in the business’s future under Siemens’ leadership, stating there are no plans to part with it at present.
Also read: Richard Parsons, Former Time Warner CEO and Citigroup Chair, Dies at 76
